9096 POSTER EGFR-targeting Chimeric Monoclonal lgG-1 Antibody Cetuximab in a Phase ll/lll Study Added Either to Gemcitabine Followed by Docetaxel or Carboplatin Plus Gemcitabine for Chemonaive Patients With Advanced Non-small Cell Lung Cancer (NSCLC) – Results of the Phase II Study Part

Authors :: Kortsik, C.
Schmid-Bindert, G.
Pilz, L.R.
Cicenas, S.
Eschbach, C.
Kollmeier, J.
Schumann, C.
Serke, M.
Steins, M.
Manegold, C.
Source :: European Journal of Cancer. Sep2011 Supplement 1, Vol. 47, pS621-S621. 1p.
Publication Year :: 2011

Full Text Access

Tools